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Dengue has been well recognized as a global public health threat, but only sporadic epidemics and imported cases were re-
ported in recent decades in China. Since July 2014, an unexpected large dengue outbreak has occurred in Guangdong province, 
China, resulting in more than 40000 patients including six deaths. To clarify and characterize the causative agent of this out-
break, the acute phase serum from a patient diagnosed with severe dengue was subjected to virus isolation and high-throughput 
sequencing (HTS). Traditional real-time RT-PCR and HTS with Ion Torrent PGM detected the presence of dengue virus sero-
type 2 (DENV-2). A clinical DENV-2 isolate GZ05/2014 was obtained by culturing the patient serum in mosquito C6/36 cells. 
The complete genome of GZ05/2014 was determined and deposited in GenBank under the access number KP012546. Phylo-
genetic analysis based on the complete envelope gene showed that the newly DENV-2 isolate belonged to Cosmopolitan gen-
otype and clustered closely with other Guangdong strains isolated in the past decade. No amino acid mutations that are obvi-
ously known to increase virulence or replication were identified throughout the genome of GZ05/2014. The high homology of 
Guangdong DENV-2 strains indicated the possibility of establishment of local DENV-2 circulation in Guangdong, China. 
These results help clarify the origin of this epidemic and predict the future status of dengue in China.  
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Dengue has become the most widespread mosquito-borne 
virus disease, and the number and severity of dengue out-
breaks have increased in recent three decades. Some 3.9 
billion people living in tropical and sub-tropical regions are 
at risk of dengue virus (DENV) infection, resulting in 
500000 severe dengue cases that require hospitalization 
each year [1]. DENV infection in humans can cause a wide 
range of clinical manifestations, from mild febrile disease to 
potentially fatal dengue shock syndrome [2]. DENV can be 
classified into four serotypes (DENV-1 to DENV-4), and 
the progression to more serious disease is frequently associ-
ated with secondary infection by heterologous serotypes [3]. 
No approved vaccine or specific drug is currently available 
for the prevention and treatment of dengue. Current efforts 
to curb dengue transmission depend entirely on control of 
the mosquito vectors or interruption of human-mosquito 
contact [4]. 
In mainland China, dengue fever is still characterized as 
an imported epidemic disease, and so far has not been con-
1150 Zhao H, et al.   Sci China Life Sci   December (2014) Vol.57 No.12 
firmed to be endemic [5]. However, the threat of dengue 
epidemics in China is increasing, due to the rapid urbaniza-
tion and environmental and climate factors [6]. Guangdong 
province lies in southeastern China, characterized with hu-
mid subtropical climate, where the Aedes mosquitos are 
widely distributed and can breed throughout the year. 
Guangdong is the major affected area by DENV in main-
land China, and sporadic epidemics caused by imported 
cases have been frequently reported in the past decades [7]. 
Since July 2014, an unexpected large dengue epidemic 
has occurred in Guangdong, China. Till 31 October, a total 
of 44497 dengue fever cases have been reported, resulting 
in six deaths. It is urgently needed to isolate and character-
ize the circulating pathogen responsible for this epidemic. 
In the present study, we isolated a clinical DENV-2 strain 
from the acute phase serum of a patient with severe dengue, 
and the genetic characterization of this newly isolate has 
provided useful information to understand the origin of this 
epidemic.  
1  Materials and methods  
1.1  Case description and laboratory diagnosis 
On 30 August 2014, an 87-year-old female patient, resident 
of Guangzhou city, with a history of encephalatrophy, renal 
calculus and cholecystolithiasis, was referred for admission 
in Guangzhou 8th People’s Hospital, with complaints of 
fever, chill, severe myalgia and confusion. She suddenly fell 
ill three days before hospitalization. Acute and convalescent 
phase sera were collected for standard blood examination 
and molecular diagnosis. The patient was managed empiri-
cally by fluid therapy; all symptoms disappeared and labor-
atory parameters put back on 11 days post hospitalization. 
She finally recovered and was discharged on 12 September 
2014. 
The acute phase serum from the patient was subjected to 
real-time RT-PCR assay (DAAN, China) and IgM and IgG 
capture ELISA (PanBio, Australia) according to the manu-
facturers’ instructions. The convalescent phase serum was 
collected for immune fluorescence assay to confirm the vi-
rus isolate. The study was approved by the Review Board of 
Guangzhou 8th People’s Hospital, and informed consent 
was obtained from the patient. 
1.2  Virus isolation and identification 
Acute phase serum from the patient was inoculated in C6/36 
mosquito cells and maintained in 1640 medium (Life 
Technologies, USA) supplemented with 2% fetal bovine 
serum (Life Technologies) at 28°C in 5% CO2. When com-
plete cytopathic effects (CPE) were observed [8,9], culture 
supernatant was collected and stored at −70°C until use. 
Indirect immunofluorescence assay (IFA) was performed 
with the convalescent phase serum as previously described 
[10]. In brief, confluent BHK-21 cells were infected with 
new isolate GZ05/2014. Cells were harvested 4 days post 
infection, and suspended in DMEM containing 10% FBS. 
The suspended cells were then inoculated onto slides and 
incubated for 6 h at 37°C to be adherent. Following this, the 
slides were rinsed and fixed with acetone for 30 min in 
20°C. The patient’s convalescent phase serum diluted (100 
fold) in PBS was added on it. After incubation for 1 h at 
37°C, the slides were washed three times in PBS. Then, 
Alexa Fluor®488 conjugated goat anti-mouse IgG (Life 
Technologies) was added and incubated for 30 min at 37°C. 
DAPI was used for nucleus staining for 5 min at room tem-
perature. Finally, positive cells were detected using a fluo-
rescence microscope (Olympus, Japan). 
1.3  High-throughput sequencing (HTS) 
Total RNAs from 400 µL virus culture supernatant were 
extracted with High Pure Viral RNA Kit (Roche, Germany), 
and mixed with 1 µL 10× RNase III reaction buffer and    
1 µL RNase III at 37°C for 2 min to fragment the RNA 
molecules (Ion Total RNA-Seq Kit V2). The fragmented 
RNA was purified with 5 µL nucleic acid binding beads 
followed by the construction of whole transcriptome library 
including RNA adaptor ligation and reverse-transcription. 
The cDNA was purified, amplified, and checked by 2100 
bioanalyzer (Agilent, USA). The library was sequenced 
using an Ion Torrent 318 chip on the Personal Genome 
Machine® (PGM, Life Technologies) according to the man-
ufacturer’s instructions. During analysis of sequence reads, 
the short (less than 30 bp) reads were filtered and low qual-
ity (Q value<20) bases were trimmed. Remaining sequences 
were searched against the reference viral genome database 
(ftp://ftp- trace.ncbi.nlm.nih.gov/refseq/release/viral/) using 
BLAST+ 2.2.26 with an E-value cutoff of 103. The reads 
were de novo assembled and/or mapped to a reference 
DENV genome using Newbler 2.9 (Roche).  
1.4  Complete genome sequencing 
Total RNA was extracted using the Purelink RNA mini kit 
(Life Technologies) from C6/36 culture supernatant infected 
by isolated virus. Next, cDNA was produced using M-MLV 
reverse transcriptase (TaKaRa, Japan) with a specific re-
verse primer, and 13 primer pairs were used to generate 
overlapping amplicons spanning the entire genome. The 
PCR products were sequenced and assembled. The 5′ and 3′ 
untranslated regions (UTRs) of viral genome of the isolate 
were determined using a rapid amplification of either 5′ or 
3′ cDNA ends (RACE) kit (Roche) following the manufac-
turer’s recommendation. All primers are listed in Table S1 
in Supporting Information. 
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1.5  Sequence alignment and phylogenetic analysis 
Multiple sequence alignment was carried out employing the 
CLUSTAL W program [11,12]. Phylogenetic analyses 
based on the nucleotide sequence of complete envelope (E) 
gene of 37 DENV-2 were carried out by Neighbor-Joining 
method using MEGA version 5.05. The Neighbor-Joining 
trees were constructed by Tamura-Nei model with gam-
ma-distribution of among-site. Sequences of the DENV-1 
strain WestPac, DENV-3 strain H87 and DENV-4 strain 
H241 were used as outgroups. 
2  Results 
The patient was clinically diagnosed as severe dengue ac-
cording to the 2014 guideline of National Health and Fami-
ly Planning Commission of China and the 2009 guideline of 
WHO/TDR [4]. The laboratory parameters of the patient are 
shown in Table 1. Laboratory tests on peripheral blood ex-
amination showed severe thrombocytopenia occurred with-
out increased hematocrit, and significant leukopenia, and 
hemoglobin decrease. The tourniquet test was positive. On 
abdominal ultrasonic examination, gall bladder thickening 
and multiple calculi were observed without hepatomegaly. 
The patient presented plasma leakage and severe organ in-
volvement.  
The acute phase serum was collected for nucleotide de-
tection, and DENV-specific real-time RT-PCR showed pos-
itive results for DENV-2. However, DENV-specific IgM 
and IgG antibody were not detected in the patient serum 
(Table 1). Then, the acute phase serum was directly inocu-
lated into C6/36 cells to isolate the pathogen. To rapidly 
identify virus genome sequence, high-throughput sequenc-
ing based on Ion Torrent was used to analyze the initial cell 
culture supernatants incubated with the patient sera. A total  




Platelet count (×109 L1) 6 100300 
WBC1 (×109 L1) 2.5 4.010.0 
Hemoglobin (g L1) 117 120160 
Hematocrit (%) 43 4050 
Albumin (g L1) 33 3555 
LDH2 (U L1) 353 120230 
ALT3 (U L1) 39 540 
AST4 (U L1) 78 540 
BUN5 (mmol L1): 5.9 2.980.2 
Creatinine (μmol L1) 177 44133 
Specific DENV-IgM 2.36 >11 
Specific DENV-IgG 3.74 >22 
Nucleic acid detection DENV-2  
a) 1WBC: white blood cells; 2LDH: lactate dehydrogenase; 3ALT: ala-
nine transferase; 4AST: aspartate transferase; 5BUN: blood urea nitrogen. 
of 5240533 reads from raw sequencing data with average 
length of 106 bp were preprocessed by custom script. The 
home-made pathogen identification pipeline (AutoMetaA-
nalysis) detected 534 reads matched with DENV-2. The 
matched reads were then searched against NCBI nucleotide 
database using BLAST+ program and the results demon-
strated that these sequences have the most similarity with 
DENV-2 isolate GZ40 (accession number JX470186). Us-
ing JX470186 as a reference, 2263 reads from the raw se-
quencing data were mapped to the reference genome and 
the average coverage was 23.45. The assembled virus ge-
nome sequence has an identity of 98% with the reference 
genome. This result indicates that DENV-2 was the causa-
tive agent of disease.  
Five days post inoculation on the second passage in 
C6/36 cells, typical cytopathic effects (CPE) caused by 
DENV infection, characterized by cell fusion, enlargement, 
aggregation, swelling and vacuoles formation (Figure 1) 
were observed. The newly isolated DENV-2 was further 
identified by IFA, and the results showed that the patient’s 
convalescent phase serum was fully reactive to the newly 
isolated virus (Figure 2). We named this clinical DENV-2 
strain as GZ05/2014.  
Further, routine RT-PCR was performed with virus cul-
ture to amplify the whole genome as previously described. 
The complete genome sequences of GZ05/2014 were finally 
obtained and submitted to GenBank under the accession 
number KP012546. The entire genome of DENV-2 strain 
GZ05/2014 is 10723 nt in length. The length of the 5′ and 
3′-untranslated regions are 96 and 451 nt, respectively. The 
only open reading frame is predicted to encode a large pol-
yprotein of 3392 amino acids.  
Phylogenetic analysis based on E gene classified all 
DENV-2 isolates into five genotypes. The newly isolated 
DENV-2 strain GZ05/2014 belonged to the genotype Cos-
mopolitan, clustering closely with other DENV-2 isolates 
circulating in Guangdong, China from 2001 to 2013 (Figure 
3). Other DENV-2 strains isolated in the 1980s in China 
belong to Asian I, Asian II, and American/Asian genotype, 
respectively. Especially, sequence alignment demonstrated 
that the E protein of GZ05/2014 has the 100% amino acid 
homology to strains GZ26199 (accession number KJ807- 
797), ZH413-2 (accession number KC131142) and GZ257 
(accession number KJ277886) isolated from 2013, 2012, 
and 2001, respectively. The E protein of GZ05/2014 has 
above 99.8% amino acid homology to other strains isolated 
from the same region since 2001. This result demonstrates 
that the newly isolated DENV is not “complete novel” to 
Guangdong, the virus being there for a long time.  
Finally, to identify whether there is any potential amino 
acid variation that would increase the virulence, the complete 
genome of GZ05/2014 was compared with other DENV-2 
strains isolated in Guangdong, China. As shown in Table 2, 
all the critical amino acids retained identical among the 
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Figure 1  The cytopathic effects (CPE) in C6/36 cells. A, C6/36 cells on 5 days post inoculation with the patient acute phase serum. B, Control C6/36 cells. 






















Biological impacts Reference 
E 67 N N N N N N N N N N 
N67Q: decreased virus 
growth 
[13] 
 71 A A A A A A E A D E E71D: increased mouse 
neurovirulence 
[14] 
 104 G G G G G G G G G G 
G104S: decreased thermal 
stability 
[15] 
 124 N N N N N N N N N N 
N124D: reduced heparan 
sulfate binding affinity 
[16] 
 126 E E E E E E E E K E K126E: increased mouse 
neurovirulence 
[14,17] 
 128 K K K K K K K K K K 
K128E: reduced heparan 
sulfate binding affinity 
[16] 
 135 L L L L L L L L L L 
L135G: reduced replication 
in C6/36 cells 
[18] 
 390 S S S S S S N S N N N390H: increased mouse 
neurovirulence 
[17] 
 398 I I I I I I I I I I 
I398P: decreased the 
assembly and release 
[19] 
 405 T T T T T T T T T T 
T405P: decreased virus 
assembly and release 
[19] 
 429 F F F F F F F F F F F429P: decreased the 
assembly and release 
[19] 
 436 L L L L L L L L L L 
L436P: decreased the 
assembly and release 
[19] 
 492 M M M M M M M M M M 
M492V: increased replica-
tive fitness in native mos-
quitoes 
[20] 




 279 F NS* F F F F F F F F 
L279F: increased replica-
tive fitness in mosquitoes 
[20] 
NS4B 52 L NS* L L L L L L L L 
L52F: increased viral RNA 
synthesis 
[22] 
 245 N NS* N N N N N N N N 
N245S: increased replica-
tive fitness in mosquitoes 
[20] 




NS5 200 K NS* K K K K K K K K 
K200Q: increased replica-
tive fitness in mosquitoes 
[20] 
 290 T NS* T T T T T T T T T290I: increased replicative 
fitness in mosquitoes 
[20] 
 401 R NS* R R R R R R R R 
R401K: increased replica-
tive fitness in mosquitoes 
[20] 
a) *, NS: not sequenced. 
recent Guangdong DENV-2 isolates since 2001, which was 
in agreement with the phylogenetic analysis results. Espe-
cially, amino acid substitution at position 126 (K126E) in 
the E protein was seen in Guangdong isolates except D2-43, 
which was reported to have the neurovirulence phenotype in 
mice [23]. Amino acid substitutions at positions 71 and 390 
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Figure 2  Identification of the new DNEV-2 isolate by IFA. BHK-21 cells were infected with GZ05/2014 strain and 4 days after infection were fixed and incu-
bated with the patient’s convalescent phase serum. DAPI was used for nucleus staining. A, BHK-21 cells infected with GZ05/2014. B, Control BHK-21 cells. 
in E protein were also identified; however, their biological 
effects remain unknown. A series of mutations increased 
DENV replication and viral fitness in mosquitoes have been 
well identified [20,24], while none of them was seen in 
GZ05/2014 and other Guangdong isolates (Table 2). Cur-
rent sequence analysis failed to identify any amino acid 
mutations that would make an obvious connection between 
viral virulence and disease severity.  
3  Discussion 
In the present study, we isolated a DENV-2 clinical strain 
from a patient who was diagnosed as severe dengue during 
the large dengue fever outbreak in Guangdong, China. 
Rapid identification and characterization of the pathogen of 
an emerging epidemic is critical for disease control. Labor-
atory diagnosis of the case reported here was based on re-
al-time RT-PCR, deep sequencing, and virus isolation. This 
multi-method analysis led to the reliable detection of DENV 
infection from the patient’s serum. Virus culture is the gold 
standard for identification of DENV infections. Viral cul-
ture showed CPE indicative of virus growth, and the con-
ventional real-time RT-PCR confirmed DENV-specific vi-
ral genome sequence was present. However, virus isolation 
in cell culture takes time and can be affected by multiple 
factors. Especially, DENV infection causes CPE slowly; 
some DENV strains even do not cause obvious CPE in cell 
culture. With the rapid development of HTS and high per-
formance computing technologies, it is possible to identify 
the potential pathogen in a quick sequencing run without 
any pervious pathogen information, and the whole process 
including sample processing, library preparing, sequencing, 
and bioinformatics analyzing can be finished within 24 h. 
The HTS technology can be used as a fast and reliable 
method to detect viral pathogens in clinical samples, espe-
cially for the outbreak of endemic diseases. In this study, we 
for the first time identified the pathogen as DENV-2 from 
patient serum inoculation using HTS, and obtained 97% 
sequences of complete genome, without any prior infor-
mation about the pathogen and without amplification using 
specific primers.  
DENV-1 was predominant and responsible for the epi-
demics of dengue fever in Guangdong for decades [25]. 
However, the other three serotypes, DENV-2, DENV-3, and 
DENV-4, were all occasionally isolated in the past decade 
[2630]. The co-circulation of multiple DENV serotypes 
increased the risk of secondary infection, and a severe den-
gue case due to secondary infection emerged in Guangdong 
province in 2011 [31]. Five DENV-2 genotypes have been 
described: Asian I, Asian II, American/Asian, Cosmopolitan 
and American [7]. According to polygenetic analysis results, 
the new isolate GZ05/2014 belonged to the Cosmopolitan 
genotype, clustering with other DENV-2 isolates circulating 
in China in recent 10 years (Figure 3). However, in early 
dengue epidemic before the 2000s, Asian I, Asian II and 
American/Asian genotypes have been observed, suggesting 
that a shift to Cosmopolitan genotype has occurred. Wheth-
er dengue is endemic in Guangdong remains to be demon-
strated. Considering the fact that multiple genotypes of 
DENV-2 are co-circulating in South-Eastern Asian coun-
tries, the high homology and identical genotype of Guang-
dong DENV-2 strains suggest the possibility of establish-
ment of local DENV-2 infection in Guangdong, China. 
This unexpected large outbreak in China has raised the 
concern of the emergence of a “new” DENV with increased 
virulence or enhanced transmission. Most DENV virulence 
determinants have been well described, most of which lo-
cate at the E protein [13,1519]. A mutation at 126 in the E 
protein hinge region from a negatively charged to a posi-
tively charged amino acid (K126E) has been implicated in 
the attenuation of viscerotropism for humans [14]. However, 
there were no reports about relationship between K126E 
substitution and dengue pathogenesis in humans. A few 
substitutions in NS1, NS4B, and NS5 protein were evi-
denced to increase viral replicative fitness in native mos-
quitoes, and contribute to DNEV genotype clade replace-
ment [20,24]. None of these mutations existed in the new 
isolate GZ05/2014. In addition, the amino acid mutations 
affecting the viral temperature sensitivity and viral RNA 
synthesis [21,22] were also compared with the new isolate 
GZ05/2014, and no enhancement signal was observed. Most  
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Figure 3  Phylogenetic analyses of DNEV-2 isolates based on the complete envelope gene using the Neighbor-Joining method by Tajima-Nei model. 
GZ05/2014 isolated in this study is marked with red triangle, and all Chinese isolates are shown in red. DENV-1 strain WestPac, DENV-3 strain H87 and 
DENV-4 strain H241 were used as outgroups. 
importantly, these critical amino acids are identical among 
all the DENV-2 isolates in Guangdong from 2001 to 2014, 
indicating that genetic characterization of DENV-2 strains 
circulating in Guangdong remains stable since its introduc-
tion in the 2000s. Current genomic analysis of GZ05/2014 
has not yet explained the scale of this dengue epidemic and 
the severity of disease. Further phenotype characterization 
and virulence analyses using reverse genetic technology 
should be warranted in the future. 
Currently, multiple serotypes of DNEV are circulating in 
Guangdong (unpublished data), and the origins and biolog-
ical properties of these DENV isolates remain to be deter-
mined. Our study reports the first complete genome se-
quence of a clinical DENV-2 isolate during this severe out-
break in China. Extensive virological studies and compre-
hensive epidemiological investigation are underway to fight 
against DENV infection. 
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